| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 60.014 | 108.441 | 136.189 | 142.392 | 169.543 |
| Total Income - EUR | - | - | - | - | - | 60.014 | 108.441 | 136.189 | 142.392 | 169.546 |
| Total Expenses - EUR | - | - | - | - | - | 17.825 | 52.308 | 18.955 | 16.614 | 31.241 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 42.189 | 56.133 | 117.234 | 125.778 | 138.305 |
| Net Profit/Loss - EUR | - | - | - | - | - | 41.045 | 55.070 | 115.921 | 124.354 | 133.219 |
| Employees | - | - | - | - | - | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Nova Atriamedical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 3.381 | 2.734 | 2.170 | 1.592 | 63.471 |
| Current Assets | - | - | - | - | - | 41.829 | 55.326 | 114.513 | 20.545 | 137.764 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 29.824 | 38.773 | 113.177 | 13.052 | 134.204 |
| Cash | - | - | - | - | - | 12.005 | 16.553 | 1.335 | 7.493 | 3.560 |
| Shareholders Funds | - | - | - | - | - | 41.086 | 55.111 | 115.961 | 15.763 | 133.259 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 4.123 | 2.950 | 721 | 6.373 | 67.976 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Nova Atriamedical S.r.l.